drugset / Trial / NCT00690833

Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis

NCT00690833

Phase 4 Completed 41 enrolled Wake Forest University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to better understand how this study drug works when people use it to treat atopic dermatitis. Desonate has been approved by the US Food and Drug Administration (FDA) for atopic dermatitis.

Timeline

Start
2007-08
Primary completion
2007-12
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Desonide Small molecule 0.05 % Topical

Indications